differentiate, under appropriate culture conditions, into cells able to secrete an extracellular matrix undergoing mineralisation and to express markers typical for osteogenic differentiation (12) (13) . These cells represent a promising approach for regenerative therapy in dentistry, but the identification of specific markers of their osteogenic differentiation is still incomplete. Osteocalcin (OCN), osteonectin, alkaline phosphatase (ALP) as well as bone sialoprotein (BSP) and dentin sialophosphoprotein (DSPP) have been used as mineralisation markers for odontoblast/ osteoblast-like differentiation, and there is a general agreement that these molecules are enhanced during, and may favour differentiation and mineralisation of pulp-or papilla-derived MSCs (13) (14) . In contrast, the role and the behaviour of the recently identified matrix extracellular phosphoglycoprotein (MEPE), a non-collagenous protein found in human bone and dental tissue (15) (16) , is still a matter of debate. MEPE is a member of the small integrin-binding ligand N-linked glycoprotein (SIBLING) family, which include osteopontin (SPP1), dentin-matrixprotein-l (DMP-l), BSP and DSPP, which have many features in common (17) . The gene coding for MEPE was discovered to be clustered in the q21.1 region in human chromosoma 4 (18) and its mutations are related to pathological bone and dentin mineralization, confirming the important role it has in these processes (19) (20) . MEPE is expressed in bone during the proliferation and early maturation phases by osteoblasts (21) , whereas it is downregulated during terminal differentiation of human osteoblasts derived from bone (22) . MEPE is expressed also in osteocytes and may play an important role in inhibiting bone mineralisation and formation, being implicated in phosphate homeostasis and bone metabolism in humans (23) (24) (25) . A similar role might be played by MEPE in dental tissues. Indeed, a fragment of MEPE, named dentonin, was recently shown to enhance the proliferation of dental pulp stem cells in vitro (26) and to stimulate the initial cascade of events leading to pulp healing response to injury in vivo (27) . Conversely, MEPE expression results dowregulated as dental pulp stem cells differentiate (16) . However, results are not univocal and a persistently increased MEPE expression was very recently shown in dental pulp cell odontogenic differentiation (14) . MEPE behaviour has been very little been investigated in human dental papilla mesenchymal cells (PaMCs) (28) . Therefore, in this paper, we want to characterise the expression of MEPE in PaMCs deriving from human impacted third molars. Taking into consideration the role mostly played by MEPE in differentiating bone-or dental-derived MSCs, MEPE expression was analysed in relation to either the proliferation rate of PaMCs or their differentiation into osteoblasts over a prolonged period (up to 40 days). Parallel experiments were carried out using mesenchymal cells deriving from human dental pulp (DPMCs), to appreciate eventual differences existing between the two cell types.
MATERIALS AND METHODS

Cell culture
Ten healthy patients (aged 11-25 years), undergoing orthodontic treatment, gave informed consent to be treated for third molar germectomy or extraction. Dental follicles (from 11-17 year-old patients) were delicately separated from the germs, immediately after tooth extraction, and dental papillas were isolated from the central region of the follicles. Also dental pulps (from 18-25 year-old patients) were obtained immediately after tooth extraction; in brief, the dental surface was first cleansed with 0.2% clorexidine and then remnants of soft tissue and blood were mechanically removed. A 2-3 mm deep groove was cut around the tooth by sterilized diamond burs, avoiding pulp exposure. Then the tooth was fractured through the cutting line with a surgical lever, and the pulp was gently separated from the crown and root using a Gracey curette.
All the following experimental procedures were the same for samples from both dental papilla and dental pulp. Isolated tissues were digested in a solution containing a-Minimal Essential Medium (MEM, Sigma, Milan, Italy), 100 U/ml penicillin, 100 ug/ml streptomycin (Invitrogen, Milan, Italy), 500 ug/rnl clarithromycin (Menarini, Florence, Italy), 3 mg/ml collagenase type I (Sigma) and 4 mg/ml dispase (Roche, Monza, Italy), for 1 h at 37°C. Cells, separated by filtering through a 70 urn strainer (Falcon, Becton Dickinson, Franklin Lakes, NJ, USA), were resuspended in growth medium [MEM, 100 p.M 2-phospho-L-ascorbic acid, 2mM L-glutamine (Sigma), 100 U/ml penicillin, 100 ug/ml streptomycin] supplemented with 20% fetal bovine serum (FBS, Invitrogen), and centrifuged for 10 min at 1200 rpm. The pellet, resuspended in the same medium, was plated in 25cm 2 flasks. Cultures were incubated at 37°C in a 5% CO 2 , and the medium was changed twice a week.
In vitro osteogenic differentiation
Adherent cells were trypsinised (0.025% trypsin/O.04% EDTA dissolved in phosphate buffered saline (PBS), 10 min, 37°C) and seeded on culture plates. Three days after replating the cells were switched to an osteogenic medium [growth medium supplemented with 15% FBS, 10 mM glycerol-2-phosphate disodium salt, 50 ug/ml 2-phospho-L-ascorbic acid, and 10 nM dexamethasone (Sigmaj]' up to 40 days in vitro (DIV).
Cell proliferation analysis
Cell proliferation was assayed by 3-(4,5dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay, using the CellTiter 96® AQueous One Solution Cell Proliferation Assay (Promega, Milan, Italy), according to the manufacturer's instructions. The absorbance was measured at 490 nm, using a microtiter plate reader (Spectracount''", PerkinElmer, Waltham, MS, USA). In addition, the number of viable cells was detected by the trypan blue exclusion test. At the indicated times, cells were trypsinized, added with trypan blue (0.15%) for 5 min and then counted by hemocytomer under a microscope.
FACS analysis
Primary cultured cells were trypsinised, washed twice with PBS and incubated with different monoclonal antibodies (CDl4-FITC, CDl5-FITC, CD29-PE, CD34-PE, CD45-PE, CD90-FITC, CDlI7-PE, CDl46-PE and CDl66-PE, all from Becton Dickinson, or STRO-I-FITC from Santa Cruz Biotechnologies, Santa Cruz, CA, USA) at room temperature for 30 min in a dark room. Cells were then fixed and lysed with FACS lysing solution (Becton Dickinson), washed with PBS and analysed in a Becton Dickinson FACS flow cytometer using Cell Quest software. The calibration was carried out with four colours using Calibrite3 plus APC (Becton Dickinson) and analysed by FACScomp software.
Evaluation of calcium accumulation by Alizarin Red staining
To enable visualisation of calcium accumulation in cultured cells after the in vitro osteogenic differentiation, we used Alizarin Red staining. Briefly, cells were cultured in the presence of 50 ug/ml ascorbic acid, 10 mM~ glycerophosphate and 10 mM dexamethasone to induce nodule formation for a period of 3 weeks. After cell exposure to osteogenic condition, samples were fixed with 4% paraformaldheyde overnight, rinsed in PBS and stained for 10 min with 40 mM Alizarin Red Solution, pH 4.2, at room temperature.
RNA isolation and Northern Blotting
Total RNA was isolated from the cells using TRIzol reagent (Invitrogen) according to the manufacturer's recommendations. The resulting RNA pellet was redissolved in 30 III diethyl-pyrocarbonate-treated water and 5 ug were run on formaldehyde denaturing gel to confirm the integrity of the RNA. To remove any genomic DNA contaminants, RNA samples (10 ug) were treated with 1 U DNase-I RNase-free (Roche). First strand cDNA was synthesised from 1.5 ug of total RNA using the RT-PCR system RETROscript™ (Applied Biosystem, Milan, Italy) with random hexamers. The resultant cDNA (2 Ill) was amplified in a 100 III reaction volume containing PCR reaction buffer, 1.5 mM MgCI 2 , 0.2 mM each deoxy-dNTP, 1 IlM oligonucleotide primers (MWG Biotech, Ebersberg, Germany), 2.5 U AmpliTaq Gold™ DNA polymerase (Applied Biosystems). The following human primers were used: ALP (Accession Number BC066116.1)
Conditions applied for PCR amplification were 94°C for 5 min, 35 cycles of denaturation at 94°C for 1 min, annealing at 55°C (ALP and MEPE) or 58°C (OCN and GAPDH) for 1 min and elongation at noc for 1 min. Reaction was also performed without the reverse transcriptase step as control for genomic contamination. Amplification products were resolved by 1.5% agarose gel electrophoresis. The identity of the products was confirmed by cycle sequencing the amplified cDNA. For Northern blot analysis, 20 ug/lane of extracted RNA were electrophoresed on a 1% denaturing agarose gel and transferred to Hybond-N filters (GE Healthcare Life Sciences, Milan, Italy). The filter was then UV crosslinked in UV Stratalinker 1800 (Stratagene). The blots were pre-hybridised for at least 8 h at 42°in a solution containing 50% formammide, 5x Denhardt's Solution, 5x SSC, 0.1% sodium dodecyl-sulphate (SDS) and 100 ug/ml salmon sperm DNA (Sigma) and hybridization of cDNA probes was performed in a buffer of the same composition containing 10 6 cprnlml of radiolabelled probe. The probes were generated by RT-PCR with the primer pairs abovementioned. PCR products were extracted from agarose gel slices (Millipore, Bedfore, MA USA) and radiolabelled by the method of random priming (Megaprime DNA labelling system) using [ 32P]_dCTP (GE Healthcare Life Sciences). After hybridization, blots were washed in 0.1x SSC containing 0.1% SDS at 50°C and exposed to Kodak Biomax MS autoradiography film. To assess the RNA level in each lane, stripped filters were re-hybridised with a GAPDH labelled probe. The intensity of bands was quantified by densitometric analysis (Molecular Analyst System, Bio-Rad Laboratories). MEPE, ALP, and OCN mRNA signals were normalised against GAPDH content.
Western Blot analysis
Cells were harvested at 4°C in a lysis buffer (in mM: Tris buffer 50, NaCI 150, PMSF 1.0; 1% Nonidet-P40, 5 ug/rnl leupeptin, 5 ug/ml aprotinin), disrupted by sonication and centrifuged (14,000 rpm, 5 min, 4°C). Protein concentration was determined by BioRad protein assay (Bio-Rad Laboratories, Milan, Italy). Samples (50 ug), diluted in SDS-bromophenol blue buffer, were boiled (5 min) and separated on 12.5-15% SDS-polyacrylamide gels. Proteins were transferred on a polyvinylidene fluoride membrane, blocked with PBS/O.I% Tween20/ 5% non-fat milk (Bio-Rad Laboratories) for 2 h at 4°C, incubated overnight at 4°C with specific primary antibodies [polyclonal rabbit anti-human ALP dilution I: 10.000, anti-human OCN dilution I :200 (abeam, Cambridge, UK) and anti-human MEPE I ug/ml (R&D, Minneapolis, MN, USA)] for I h at room temperature and then repeatedly washed and exposed to donkey anti-rabbit HPR-conjugated secondary antibody for I h at room temperature (GE Healthcare Life Sciences; final dilution I :5000). To determine the equal loading of samples, the blots were stripped and re-probed with an anti-B-actin antibody (dilution 1:100, incubation for lh at room temperature; Santa Cruz Biotechnologies). Immunocomplexes were visualised using the enhancing chemiluminescence (ECL) detection system (GE Healthcare Life Sciences) and quantified by densitometric analysis (Molecular Analyst System).
SEM imaging ofcells on granule surface
For scanning electron microscopic studies, granules of hydroxyapatyte (Engipore, Fin-Ceramica, Faenza, Italy; particle size, 0,25-1 mm; 200 mg/dish) were added to the cells after re-seeding. The cells, cultured for 4 weeks in osteogenic condition (see above), were washed in 0.1 M phosphate buffer/O.15 M sucrose, to ensure that the osmolarity remained at about 360 mOsm, prefixed for 10 h at 4°C in 5 ml of 2% glutaraldehyde/0.05 M phosphate buffer (pH 7.2) and washed again with buffer solution. The specimens were treated with I% osmium tetroxide for 5 h, washed in 0.1 M phosphate buffer/O. 15M sucrose, and then dehydrated using both a graded alchool series and a CO 2 Critical Point Dried (CPD) in an Emitech K850 (Emitech Ltd. Ashford, Kent, UK). Samples were mounted onto the aluminium stubs using carbon adhesive discs, and very lightly gold sputtered in an Emitech K550 (Emitech Ltd. Ashford) before imaging by means of a Scanning Electron Microscope (SEM) (Leo 435 Vp Cambridge, UK).
Statistical analysis
All experiments were performed either three or four times. Northern and Western blots are presented as representative results. The quantitative data are expressed as mean ±SEM. Time-response curves were calculated by using non-linear regression (Prism3 software, San Diego, CA, USA). Statistical analyses were performed by Prism3 software (GraphPad), using one-way analysis of variance (ANOVA) followed by Dunnett's post hoc comparison test. Group differences with P<0.05 were considered statistically significant.
RESULTS
Isolation and characterisation of cultured cells derivedfrom human dental pulp and papilla
Primary cultures of mesenchymal cells were obtained from human pulp and papilla tissues, which are constituted by a heterogeneous population containing progenitor/stem cells of odontoblast lineage (11, 13, 28) . During the first three-four DIV, floating cells and debris were removed by culture medium change and adherent cells from both tissues exhibited a typical spindle-like shape, resembling fibroblasts. As previously shown (29) , the immunophenotype characterisation of these cells by cytofluorimetric analysis, using a panel of specific antibodies against known antigens associated with different phenotypes, confirmed that primary cultures of papilla cells, like those from dental pulp, were negative for hematopoietic markers CDI4, CDI5, CD45, CD34 and CD117/ c-kit, whereas about 90% or more positively expressed mesenchymal cell markers, such as CD90, CD166, CD29, and endothelial cell marker CD146. Additionally, more than 30% of both cell types expressed mesenchymal stromal progenitor marker STRO-l, which has been identified together with CD146 as early mesenchymal stem cell marker on both bone marrow and dental pulp MSCs ( Fig. 1 and Table I) .
Interestingly, the two cell types exhibited a different proliferation rate ( Fig. 2A ). The number whereas DPMCs reached the confluence later, after the 10_12 th DIY. Also MEPE expression was different in PaMCs and OPMCs. Northern and Western blot analyses showed that MEPE expression at both mRNA and protein level was greater in DPMCs than in PaMCs at the 3 rd DIY, but it down-regulated earlier (5 th DIY) in PaMCs than in DPMCs (10 th DIY) ( Fig. 2B) . Such behaviour paralleled the pattern of cell proliferation and resulted faster in PaMCs.
DPMCs
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In vitro mineralisation and attachment behaviour on a conventional scaffold
To investigate the potential ofPaMCs and DPMCs to undergo odontoblastic/osteoblastic differentiation, cells at passage two were supplemented with L-ascorbate-2-phosphate, dexamethasone and inorganic phosphate to induce mineralisation. Small round Alizarin Red-positive nodules formed in the cultures were observed at three weeks of induction onward, indicating calcium accumulation (Fig. 3) . The results shown in Fig. 3 are representative of several independent experiments with consistent results and indicate that calcium accumulation in the extracellular matrix of PaMCs and OPMCs was similar. Therefore, these data confirm the capability of osteogenic differentiation of cultured cells obtained from dental papilla tissue.
Moreover, we combined cells from dental papilla or pulp wih hydroxyapatyte granules and observed cell morphology and capability of colonizing this conventional scaffold after four weeks in culture by scanning electron microscopy (Fig. 4 ). This analysis demonstrated that both OPMCs and PaMCs were able to adhere to the substrate, forming a confluent multilayer with the same mode of adhesion and time of spreading.
Expression ofosteoblastic markers after exposure of PaMCs or DPMCs to differentiation medium
In PaMCs and DPMCs exposed to the osteogenic medium we measured, over a period of 40 DIY, the expression/intracellular content of selected osteoblastic markers , such as ALP and OCN in comparison with MEPE. Under osteogenic conditions, the expression and the protein content of ALP and MEPE resulted remarkably greater in DPMCs than in PaMCs. However, ALP and OCN resulted up-regulated whereas MEPE expression was downregulated faster in differentiating PaMCs than in DPMCs ( Fig. SA-C) . For both types of cells, ALP levels returned to control values at the 40 th DIY, whereas the expression/intracellular content ofOCN remained constantly elevated over this period. 
DISCUSSION
The evidence that post-natal dental tissues contain MSCs able to differentiate into odontoblastsl osteoblasts, potentially useful for dental tissue regeneration, has encouraged research in this field. Most articles deal with the differentiation and regeneration properties of MSCs deriving from human adult dental pulp, human primary teeth and periodontal ligament (11, (30) (31) (32) (33) (34) .
Recently, some authors (12) (13) 28) pointed out that MSCs may be isolated from human dental papilla. We confirm that cells derived from this source express a number of mesenchymal markers, such as cells isolated from impacted third molar pulp. Interestingly, both PaMCs and DPMCs were negative for CD 117/c-kit, like cells from human parodontal ligament and bone marrow (33, 35) , but differently from pulp MSCs of both deciduous and adult teeth (30) (31) . Moreover, they were both positive for STRO-l, an early marker of osteogenic precursors, and even more for CD 146, an endothelial marker. This finding indirectly suggests that also cells from dental papilla derive from a perivascular niche, as observed for bone marrow and dental pulp MSCs (7) .
We also found that undifferentiated PaMCs exhibit a higher proliferation rate in comparison with DPMCs. Our data are in agreement with those recently reported by Sonoyama et al. (13, 28) on this aspect. Thus, dental papilla, a developing tissue with the additional great advantage of being virtually infection-free, is a good source of mesenchymal cells owing to its high proliferative potential and, at the same time, it is inexpensive deriving from a generally discarded source in orthodontic dentistry like impacted teeth.
Interestingly, we demonstrate that, before cell differentiation, the higher rate of duplication of PaMCs is coupled to an earlier down-regulation of MEPE. Since dentonin, a fragment of this protein, may promote proliferation of MSCs in vitro (26) , it is conceivable that this protein is down-regulated as soon as cells become confluent.
Our data also confirm the potential of mesenchymal cells from dental papilla to undergo odontoblastic/osteoblastic differentiation. Indeed, we observed small round Alizarin Red-positive nodules after three weeks of induction, indicating calcium accumulation in vitro. The same cells also showed a good ability to anchor a biomaterial, widely used as a scaffold for reconstructive surgery, such as MSCs derived from dental pulp (36) . Moreover, under osteogenic condition, we revealed the expression of two osteogenic markers, ALP and OCN, in PaMCs, which resulted lower than in OPMCs, as recently reported by Sonoyama et al. (28) . We also found an upregulation of these two markers, occurring earlier in PaMCs than in OPMCs along an exposure period of 40 days to conditioning medium. These data might indicate that PaMCs, in comparison with OPMCs, comprise a greater number of progenitors undergoing osteogenic differentiation. This could represent a further favourable feature to usefully employ PaMCs for hard tissue regeneration.
Interestingly, we found that MEPE expression, revealed by Northern and Western blot analyses, was down-regulated as PaMCs and OPMCs differentiated. These findings are in agreement with those showing MEPE down-regulation along differentiation of human bone marrow-or dental pulp-derived MSC (16, 22) . Additionally, MEPE expression was lower but its downregulation occurred earlier in PaMCs than in OPMCs. This finding might account for the reduced expression of MEPE found found by Sonoyama et al. (28) in apical papilla-derived MSCs in comparison with dental pulp MSCs, likely depending also on the differentiation time of the cells.
Altogether, our data indicate that in PaMCs MEPE is most active in the proliferative and early stage of differentiation. Thus, also for these cells, MEPE, showing a peculiar behaviour, can be reasonably included as a marker among the others and as a further index to reveal odontoblast/ osteoblast differentiation.
